[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567749":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":32,"locations":39,"responsibleParty":157,"collaborators":159,"id":162,"slug":31,"hasResults":163,"nctId":164,"briefTitle":165,"officialTitle":166,"acronym":31,"eligibilityCriteria":167,"healthyVolunteers":163,"sex":168,"minAge":169,"maxAge":170,"enrollmentInfo":171,"targetDuration":31,"studyType":174,"phases":175,"briefSummary":177,"conditions":178,"keywords":199,"overallStatus":42,"whyStopped":31,"lastUpdateSubmitDate":214,"lastUpdatePostDateStruct":215,"startDateStruct":218,"completionDateStruct":220,"leadSponsor":222,"locationsCount":223},{"fullName":5,"class":6},"Intellia Therapeutics","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"nexiguran ziclumeran","EXPERIMENTAL","nexiguran ziclumeran 55 mg by single IV infusion",[13],"Biological: nexiguran ziclumeran",{"label":15,"type":16,"description":17,"interventionNames":18},"Normal Saline","PLACEBO_COMPARATOR","Placebo; Normal saline (0.9% NaCl) by single IV infusion",[19],"Drug: Normal Saline as Placebo",[21,26],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"BIOLOGICAL",[9],[25],"NTLA-2001",{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","Normal Saline as Placebo","Normal saline (0.9% NaCl) by single IV infusion",[15],null,[33],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},"Trial Manager at Intellia","CONTACT","1-857-285-6200","6","medicalinformation@intelliatx.com",[40,52,57,65,75,83,91,99,109,118,123,134,139,147],{"facility":41,"status":42,"city":43,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":31},"Hospital Británico de Buenos Aires","RECRUITING","Buenos Aires","Argentina","AR",{"type":47,"coordinates":48},"Point",[49,50],-58.37723,-34.61315,{"lat":50,"lon":49},{"facility":53,"status":42,"city":43,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":54,"geoPoint":56,"contacts":31},"Hospital Italiano de Buenos Aires (HIBA)",{"type":47,"coordinates":55},[49,50],{"lat":50,"lon":49},{"facility":58,"status":42,"city":59,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":60,"geoPoint":64,"contacts":31},"Hospital El Cruce","San Juan Bautista",{"type":47,"coordinates":61},[62,63],-58.27623,-34.80896,{"lat":63,"lon":62},{"facility":66,"status":42,"city":67,"state":31,"zip":31,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":74,"contacts":31},"Hospital das Clinicas da Universidade Estadual de Campinas (UNICAMP)","Campinas","Brazil","BR",{"type":47,"coordinates":71},[72,73],-47.06083,-22.90556,{"lat":73,"lon":72},{"facility":76,"status":42,"city":77,"state":31,"zip":31,"country":68,"countryCode":69,"cosmosGeoPoint":78,"geoPoint":82,"contacts":31},"HCFMRP - Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto","Ribeirão Preto",{"type":47,"coordinates":79},[80,81],-47.81028,-21.1775,{"lat":81,"lon":80},{"facility":84,"status":42,"city":85,"state":31,"zip":31,"country":68,"countryCode":69,"cosmosGeoPoint":86,"geoPoint":90,"contacts":31},"Instituto de Educacao, Pesquisa e Gestao em Saude","Rio de Janeiro",{"type":47,"coordinates":87},[88,89],-43.18223,-22.90642,{"lat":89,"lon":88},{"facility":92,"status":42,"city":93,"state":31,"zip":31,"country":68,"countryCode":69,"cosmosGeoPoint":94,"geoPoint":98,"contacts":31},"PSEG Centro de Pesquisa Clinica S.A.","São Paulo",{"type":47,"coordinates":95},[96,97],-46.63611,-23.5475,{"lat":97,"lon":96},{"facility":100,"status":42,"city":101,"state":31,"zip":31,"country":102,"countryCode":103,"cosmosGeoPoint":104,"geoPoint":108,"contacts":31},"National Institute of Medical Sciences and Nutrition - Salvador Zubiran (INCMNSZ)","Tlalpan","Mexico","MX",{"type":47,"coordinates":105},[106,107],-99.16206,19.29513,{"lat":107,"lon":106},{"facility":110,"status":42,"city":111,"state":31,"zip":31,"country":111,"countryCode":112,"cosmosGeoPoint":113,"geoPoint":117,"contacts":31},"National University Hospital","Singapore","SG",{"type":47,"coordinates":114},[115,116],103.85007,1.28967,{"lat":116,"lon":115},{"facility":119,"status":42,"city":111,"state":31,"zip":31,"country":111,"countryCode":112,"cosmosGeoPoint":120,"geoPoint":122,"contacts":31},"Singapore General Hospital",{"type":47,"coordinates":121},[115,116],{"lat":116,"lon":115},{"facility":124,"status":125,"city":126,"state":31,"zip":31,"country":127,"countryCode":128,"cosmosGeoPoint":129,"geoPoint":133,"contacts":31},"National Taiwan University Hospital","ACTIVE_NOT_RECRUITING","Taipei","Taiwan","TW",{"type":47,"coordinates":130},[131,132],121.52639,25.05306,{"lat":132,"lon":131},{"facility":135,"status":125,"city":126,"state":31,"zip":31,"country":127,"countryCode":128,"cosmosGeoPoint":136,"geoPoint":138,"contacts":31},"Taipei Veterans General Hospital",{"type":47,"coordinates":137},[131,132],{"lat":132,"lon":131},{"facility":140,"status":125,"city":141,"state":31,"zip":31,"country":127,"countryCode":128,"cosmosGeoPoint":142,"geoPoint":146,"contacts":31},"Chang Gung Medical Foundation - Linkou Branch","Taoyuan",{"type":47,"coordinates":143},[144,145],121.29696,24.99368,{"lat":145,"lon":144},{"facility":148,"status":42,"city":149,"state":31,"zip":31,"country":150,"countryCode":151,"cosmosGeoPoint":152,"geoPoint":156,"contacts":31},"Siriraj Hospital","Bangkok","Thailand","TH",{"type":47,"coordinates":153},[154,155],100.50144,13.75398,{"lat":155,"lon":154},{"type":158,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR",[160],{"name":161,"class":6},"Regeneron Pharmaceuticals","100567749",false,"NCT06672237","A Phase 3 Study of NTLA-2001 in ATTRv-PN","MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)","Inclusion Criteria:\n\n* Diagnosis of ATTRv-PN\n* Karnofsky Performance Status (KPS) ≥ 60\n\nExclusion Criteria:\n\n* Other causes of amyloidosis (amyloidosis caused by non-TTR protein)\n* Other known causes of sensorimotor or autonomic neuropathy\n* Diabetes mellitus\n* New York Heart Association Class III or IV heart failure\n* Liver failure\n* Hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection\n* Prior receipt of a TTR silencer (Small interfering RNA (siRNA) or Antisense oligonucleotides (ASOs))\n* Estimated Glomerular Filtration Rate \\\u003C 30 mL\u002Fmin\u002F1.73 m2\n* Unable or unwilling to take vitamin A supplementation for the duration of the study\n* History of liver disease","ALL","18 Years","85 Years",{"count":172,"type":173},60,"ESTIMATED","INTERVENTIONAL",[176],"PHASE3","This study will be conducted to evaluate the efficacy and safety of a single dose of nexiguran ziclumeran (NTLA-2001) compared to placebo in participants with ATTRv-PN.",[179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198],"Neuromuscular Disease","Neuromuscular Diseases (NMD)","Neurodegenerative Disease","Neurodegenerative Disease, Hereditary","Neurodegenerative Diseases","Neuromuscular Diseases","Nerve Disorders","Nervous System Disease","Nervous System Diseases","Genetic Disease, Inborn","Amyloidosis, Familial","Amyloidosis, Hereditary","Amyloidosis","Polyneuropathies","Amyloid Neuropathies","Amyloid Neuropathies, Familial","Peripheral Nervous System Disease","Peripheral Nervous System Diseases","Metabolism, Inborn Errors","Metabolic Diseases",[200,191,201,25,202,203,204,205,206,207,208,209,210,211,9,212,213],"TTR","Polyneuropathy","ATTR","ATTR-PN","ATTRv-PN","Transthyretin","TTR-mediated amyloidosis","Amyloidosis, hereditary","Amyloidosis, hereditary, transthyretin-related amyloidosis","Transthretin amyloid polyneuropathy","TTR PN","TTR polyneuropathy","nex-z","CRISPR","2026-04-13",{"date":216,"type":217},"2026-04-16","ACTUAL",{"date":219,"type":217},"2024-11-22",{"date":221,"type":173},"2028-08",{"name":5,"class":6},14]